Compare FLC & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FLC | LFMD |
|---|---|---|
| Founded | N/A | 1994 |
| Country | United States | United States |
| Employees | N/A | 384 |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.0M | 190.9M |
| IPO Year | 2003 | N/A |
| Metric | FLC | LFMD |
|---|---|---|
| Price | $16.76 | $3.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $9.14 |
| AVG Volume (30 Days) | 22.9K | ★ 1.3M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $16.11 |
| Revenue Next Year | N/A | $20.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.80 | $2.60 |
| 52 Week High | $18.09 | $15.34 |
| Indicator | FLC | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 42.71 | 46.05 |
| Support Level | N/A | $3.43 |
| Resistance Level | $17.68 | $4.19 |
| Average True Range (ATR) | 0.22 | 0.26 |
| MACD | 0.01 | -0.08 |
| Stochastic Oscillator | 46.67 | 6.82 |
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.